 FRIENDSWOOD, Texas--BUSINESS WIRE--- CSTL castlebiosciences--Castle Biosciences Announces Publication of Clinical Validation and Utility Data for DecisionDx DiffDxTM-Melanoma for Suspicious Pigmented Lesions. 